Cite
HARVARD Citation
Heerspink, H. et al. (2018). Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy. Diabetes, obesity & metabolism. 20 (6), pp. 1369-1376. [Online].